and to excite supraoptic nucleus (SON) neurons in vivo and in vitro (6, 11, 21) . It is thought to serve as a prominent cotransmitter in the A1 catecholamine pathway that transmits information about hypovolemia and hypotension to the SON and paraventricular nucleus, because, although selective destruction of the A1 pathway prevents activation of SON neurons by hypovolemia, antagonism of PRs but not adrenergic or excitatory amino acid receptors inhibited A1-induced excitation of SON neurons (5, 6). The potential importance of ATP as a cotransmitter in this pathway is suggested by the dramatic potentiation of VP and OT release observed when ATP is applied to HNS explants in conjunction with an adrenergic agonist (13). Combined application of these agents converts the small transient increases in VP and OT release observed in response to ATP and phenylephrine alone to a large increase in hormone release that is sustained for hours.
ATP ACTS AS A NEUROTRANSMITTER in the central and peripheral nervous system. It is copackaged with other neurotransmitters in synaptic vesicles, coreleased during exocytosis of those vesicles, and activates purinergic receptors (PR) located both pre-and postsynaptically (3, 9) . There are two major classes of PRs. P2X purinergic receptors (P2XRs) are ligand gated, nonselective cation channels that are highly permeable to Ca 2ϩ . P2Y purinergic receptors (P2YRs) are G protein-coupled receptors. Multiple subtypes of both classes of receptors have been cloned and classified as P2X [1] [2] [3] [4] [5] [6] [7] and P2Y [1] [2] [3] [4] [5] [6] [7] [8] (19) . Both classes of receptors can increase intracellular calcium concentration ([Ca 2ϩ ] i ). Since P2XRs are Ca 2ϩ -permeable, ligand-gated ion channels, their activation initiates Ca 2ϩ influx through the channel. The channel is also permeable to Na ϩ , which causes membrane depolarization, allowing Ca 2ϩ influx through voltage-sensitive Ca 2ϩ channels. P2YRs are G␣ q/11 -coupled receptors and thus activate inositol triphosphate (IP 3 ), which, in turn, releases Ca 2ϩ from intracellular stores. ATP has been shown to increase vasopressin (VP) and oxytocin (OT) release from hypothalamo-neurohypophyseal system (HNS) explants (13) and to excite supraoptic nucleus (SON) neurons in vivo and in vitro (6, 11, 21) . It is thought to serve as a prominent cotransmitter in the A1 catecholamine pathway that transmits information about hypovolemia and hypotension to the SON and paraventricular nucleus, because, although selective destruction of the A1 pathway prevents activation of SON neurons by hypovolemia, antagonism of PRs but not adrenergic or excitatory amino acid receptors inhibited A1-induced excitation of SON neurons (5, 6) . The potential importance of ATP as a cotransmitter in this pathway is suggested by the dramatic potentiation of VP and OT release observed when ATP is applied to HNS explants in conjunction with an adrenergic agonist (13) . Combined application of these agents converts the small transient increases in VP and OT release observed in response to ATP and phenylephrine alone to a large increase in hormone release that is sustained for hours.
P2XRs have been implicated in these responses, because, at 10 M, a concentration that selectively antagonizes P2XRs, PPADS (pyridoxal-phosphate-6-azophenyl-2Ј,4Ј-disulphonic acid) blocked ATP-induced VP and OT release from HNS explants (13) ; the P2XR agonists, ␣,␤-methylene-ATP, ␤,␥-methylene-ATP, and 2-methylthio-ATP, mimicked the depolarizing effects of ATP on SON neurons (11) ; mRNA for several P2XR subtypes was identified in SON by RT-PCR and in situ hybridization (21) ; and ATP-induced increases in [Ca 2ϩ ] i were abolished by removing extracellular Ca 2ϩ concentration ([Ca 2ϩ ] o ) from dissociated SON neurons during imaging of the Ca 2ϩ -sensitive dye, fura-2 AM (21) . However, in the current experiments, we obtained evidence for ATP activation of P2YRs as well as P2XRs in SON neurons. ATP induced Ca 2ϩ release from intracellular stores, as well as influx of [Ca 2ϩ ] o , and P2YR agonists increased [Ca 2ϩ ] i . This is important because it may underlie integration of osmotic and hemodynamic regulation of VP release, and it is important for understanding the mechanisms underlying synergistic responses to ATP and other neurotransmitters by neurons in SON and other areas of the central nervous system.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats [Crl:CD(SD)Br; Charles Rivers Laboratories, Wilmington, MA] were used in all of the experiments. All protocols used were performed in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of Colorado at Denver and Health Sciences Center.
Calcium Imaging
Dye loading. The HNS explant preparation was prepared from 125-to 150-g male Sprague-Dawley rats. It includes the VP and OT neurons of the SON with their axons and terminals in posterior pituitary. This explant was used for live cell Ca 2ϩ imaging, as described previously (23) . The AM ester form of fura-2 (Molecular Probes, Carlsbad, CA; 50 g) was dissolved in 50 l of anhydrous dimethyl sulfoxide to make a 1 mM stock solution. Explants were incubated in 100 M fura-2 AM for 10 min followed by a 50-min incubation in 20 M fura-2 AM in medium containing 0.02% pluronic acid F-127 (Molecular Probes). Dye loading and imaging were performed in F12 nutrient medium (Sigma), fortified with 1 mg/ml glucose and 1.7 mM CaCl 2, and gassed with 95% O2-5% CO2.
Perifusion and drug delivery. Explants were placed in a chamber fitted onto the stage of an upright fluorescent microscope. The chamber was formed by an adaptor (Bioscience Tools, San Diego, CA) placed in a 35-mm Corning petri dish, whose base was coated with Sylgard (1 mm). The explant was stabilized with a weighted, ringshaped stainless steel net, which was pinned onto the Sylgard base. Gassed medium was delivered by a gravity-driven eight-valve system (Warner Instruments, Hamden, CT) to the perifusion port at a rate of ϳ3 ml/min and was removed by a vacuum port at the opposite side.
Fluorescence ratio imaging. The explant was positioned in the recording chamber with its ventral side up, stabilized with a weighted nylon mesh, and allowed to equilibrate for 1 h. Thus the optic chiasm is easily visualized, and SON can be located anatomically in the tissue immediately rostral and parallel to optic chiasm. Fura-2-loaded magnocellular neurons were alternatively excited with 340-nm and 380-nm UV light from a Xenon source (Sutter Instruments, Novato, CA). Exposure time for 380-nm wavelength was between 200 and 500 ms and was tripled for 340-nm wavelength accordingly. Emitted light was passed through a ϫ60 fluor water immersion lens attached to an Olympus upright microscope and collected at 510 nm by an intensified charge-coupled device camera (Hamamatsu, Japan). Paired 340-and 380-nm excitation images were acquired every 3 s using SlideBook software (Intelligent Imaging, Denver, CO) for a period of 100 frames. Explants treated with 10 M ionomycin to allow [Ca 2ϩ ]i to equilibrate with [Ca 2ϩ ]o gave an apparent maximum ratio (Rmax) of 1.0684 Ϯ 0.001 (n ϭ 15) in 0.3 mM Ca 2ϩ and 2.0643 Ϯ 0.0028 (n ϭ 16) in 2 mM Ca 2ϩ . As both values far exceed the highest ratio achieved by all agents studied in all experimental preparations, the peak responses reported were not limited by the maximum detectable change in the 340 nm-to-380 nm (340/380) ratio. The ratio data are presented as percentage of the basal 340/380 ratio for each cell (see below).
Data analysis. Magnocellular neurons were identified by the size of the cell body (Ͼ25 m in diameter), their location, and for some as described previously (23) , their response to VP. Data from the identified neurons were collected as the average ratio of fluorescence from 340-nm excitation over fluorescence from 380-nm excitation from a region of interest that included the complete area of the cell body, including the nucleus, if it was (rarely) evident at the focal plane of the image. This ratio is a direct, linear measurement of [Ca 2ϩ ]i within physiological ranges (10) . A baseline ratio value for each neuron was determined by averaging ratios of the 10 frames preceding drug application. Responses were then expressed as percentage changes in 340/380 ratio relative to basal. The means Ϯ SE of the percentage values from individual neurons were calculated and plotted. Parametric one-way ANOVA (F ratio) or Kruskal-Wallis oneway ANOVA on ranks (H value) were used to determine whether there were significant group differences in the peak responses. All experiments were replicated in two preparations. ANOVA was used to compare the responses between the two explant preparations in representative experiments and demonstrated that the responses were not statistically different. Therefore, additional replications were not performed.
Drug interactions with fura-2. The P2XR antagonists (PPADS, iso-PPADS, and suramin) and cadmium, a blocker of voltage-gated Ca 2ϩ channels, altered the baseline 340/380 ratio of fura 2 fluorescence in SON neurons. To evaluate the cause of this and to determine whether fura-2 could be used to assess changes in intracellular Ca 2ϩ in the presence of these agents, the effect of the agents on fura-2 340-nm and 380-nm induced emissions were analyzed in a cuvettebased assay using a QM-6/2003 fluorometer (Photon Technology International, Birmingham, NJ) using the fura-2 pentapotassium salt (45 M). The assay was validated by the demonstration that the fluorometer detected the anticipated changes in 340 nm, 380 nm, and the 340/380 ratio when the Ca 2ϩ concentration was raised to 10 mM or when EGTA was added to the buffer to render it Ca 2ϩ free (Table  1) . Also, 2 mM Mn 2ϩ , which is known to quench fura-2 fluorescence at both wavelengths, reduced both the 340-nm and 380-nm evoked emissions to barely detectable. Note, however, that, despite intense quenching, the 340/380 ratio in 2 mM Mn 2ϩ was slightly greater than control (114%) due to the 340-nm signal being slightly greater than the 380-nm signal. PPADS also quenched both 340-nm and 380-nm evoked emissions. At 100 M, the effect of PPADS on 380 nm was much greater than that on 340 nm, resulting in a substantial increase in the 340/380 ratio, but, at 10 M, the difference is much smaller so that the 340/380 ratio is only slightly increased. This concentration of PPADS and iso-PPADS was used in our current experiments. The effect of suramin was limited to the 340-nm evoked emission and, therefore, resulted in a quite large decrease in the 340/380 ratio at the concentration deemed effective to block P2 purinergic receptors. As a result, the remaining Ca 2ϩ -induced decrease in 380-nm emission was small and not a reliable indication of changes in [Ca 2ϩ ]i. Therefore, the effect of suramin was not assessed in our current experiment. Cadmium (Cd 2ϩ , 200 M) behaved like Ca 2ϩ , increasing the 340-nm Control was fura-2 (45 M) in water. All data are normalized to control and expressed as %control. The actual measurements for the control group are as follows: 340 nm, 1,410,000 counts/s; 380 nm, 1,960;000 counts/s; ratio, 0.717. 0 Ca 2ϩ was achieved by including 1 mM EGTA, the Ca 2ϩ chelator, in the testing solution; Mn 2ϩ is known to quench the fura dye. ϩ, Increase in measurements; Ϫ, decrease in measurements.
and decreasing the 380-nm evoked emissions and resulting in a large increase in the ratio. The flourometric assay clearly demonstrated that direct interaction of the antagonists with fura-2 results in differential and selective quenching of either 340-nm or 380-nm emission. This suggests that, in the current experiments, the cells were permeable to the drugs, thereby allowing the antagonists to directly interact with the dye inside the cells. This has not been reported in other studies (21, 25) , but it may reflect differences in the dye-loading protocols used in isolated or cultured cell preparations compared with the organotypic preparation used in this study. Despite the impact of these agents on fura emission, we were able to demonstrate qualitative changes in the response to ATP in the presence of PPADS and cadmium (see RESULTS) . (Fig. 3A) , the fluorometric assay demonstrated that, at concentrations Յ0.1 M, cadmium had not saturated the fura, and therefore it did not prevent detection of changes in Ca 2ϩ (Fig. 3B) . Thus, as evident in Fig. 3 , A and C, if ATP was added during the linear, nonsaturated phase of the cadmiuminduced increase in the 340/380 baseline, then changes in the ratio reflective of ATP-induced Ca 2ϩ influx were evident. To evaluate this response, the linear increase in the baseline ratio induced by the leak of cadmium into the cell was subtracted from each response. The resulting peak increase in the 340/380 ratio induced by ATP in the presence of cadmium is shown in Fig. 3D , with and without thapsigargin pretreatment. In the absence of thapsigargin, cadmium reduced the ATP-induced increase in [Ca 2ϩ ] i by ϳ50% (Fig. 3, C and D) . This response was significantly attenuated when explants were pretreated with thapsigargin to deplete intracellular Ca 2ϩ stores. However, an ATP-induced increase in [Ca 2ϩ ] i was still detectable (Fig. 3, C and D) in all of the neurons recorded. These results P2YR cocktail) . B: the response in Ca 2ϩ -free medium (0Ca.P2YR cocktail) or after TG pretreatment (TG.P2YR cocktail). C: comparison of the peak responses under these conditions. *P Ͻ 0.05, normal Ca 2ϩ vs. Ca 2ϩ -free medium (ANOVA F ϭ 3.393, P ϭ 0.038). #P Ͻ 0.05, normal Ca 2ϩ vs. TG pretreatment (ANOVA H ϭ 76.535, P Ͻ 0.001). TTX did not alter the response in normal Ca 2ϩ . Data were combined from cells imaged in 2 explants per treatment group, except for the TTX.P2YR cocktail group. The total number of neurons analyzed per group were as follows: P2YR, n ϭ 42; TTX.P2YR, n ϭ 16; 0Ca.P2YR, n ϭ 30; and TG.P2YR, n ϭ 47. The mean Ϯ SE basal 340/380 ratio preceding each response was 0.5448 Ϯ 0.0070 for P2YR, 0.5546 Ϯ 0.0119 for TTX.P2YR, 0.6426 Ϯ 0.0014 for 0Ca.P2YR, and 0.6368 Ϯ 0.0067 for TG.P2YR.
RESULTS
Source of ATP-induced [
indicate that the ATP-induced influx of [Ca 2ϩ ] o occurs primarily through voltage-sensitive Ca 2ϩ channels, with a small component coming from another source, presumably the P2XRs. This was further analyzed using PR antagonists.
PR Subtypes Activated by ATP: Effect of P2XR Antagonists
Effect of PPADS and iso-PPADS with or without thapsigargin pretreatment on ATP-stimulated [Ca 2ϩ ] i increase were assessed. Ten micromolar PPADS and iso-PPADS were used as specific P2XR antagonists. Although at concentrations Ն30 M, PPADS can also block some P2YRs, at 10 M, it is selective for P2XRs. Both PPADS and iso-PPADS increased the basal 340/380 ratio. As shown in Table 1 , although PPADS quenched both 340-nm and 380-nm fura-2 emissions, the impact on 340 nm was greater than on 380 nm, resulting in an increase in the ratio. Nevertheless, ATP-induced increases in [Ca 2ϩ ] i were still evident in the presence of both PPADS and iso-PPADS (Fig. 4, A and C) but were eliminated by thapsigargin pretreatment (Fig. 4, B and D) . These results demonstrate that blockade of P2XRs does not eliminate the response to ATP and provide further support for involvement of P2YR in the [Ca 2ϩ ] i response to ATP. Further experiments were performed using P2YR agonists to evaluate this possibility.
PR Subtypes Activated by ATP: Effect of P2YR Agonists
Effect of a P2YR agonist cocktail on [Ca 2ϩ ] i in the presence or absence of TTX. A cocktail of P2YR agonists, consisting of 2-methylthio-ADP (100 M), UTP (1 mM), and UDP (1 mM), robustly increased [Ca 2ϩ ] i (Fig. 5, A and C) . The presence of TTX (Sigma, 3 M) did not significantly change the pattern of this response (Fig. 5, A and C (Fig. 5, B and C) . The amplitude of the peak response is ϳ80% of that in normal Ca 2ϩ medium. When intracellular Ca 2ϩ stores were depleted by thapsigargin, the response to the cocktail was markedly attenuated, but a smaller increase in [Ca 2ϩ ] i persisted, which accounted for ϳ20% of the total response to the cocktail (Fig. 5, B and C) . These results demonstrated that the majority of the [Ca 2ϩ ] i increase initiated by activation of P2YRs originated from release of intracellular Ca 2ϩ stores, but Ca 2ϩ influx also makes a contribution. [Ca 2ϩ ] i in the presence or absence of TTX. The specific agonist for P2Y1R, 2-methylthio-ADP (100 M), induced a large increase in [Ca 2ϩ ] i (Fig. 6 ). This increase accounted for ϳ80% of the response to the cocktail. TTX treatment did not change this response significantly (Fig. 6) . As is the case for ATP and the P2YR agonist cocktail, essentially every SON neuron responded to 2-methylthio-ADP (Table 2 ). This result suggests that P2Y 1 R may be the predominant P2YR subtype in SON. Values are means Ϯ SE; number in parentheses is number of total neurons. 2-MeS-ADP, 2-methylthio-ADP.
Effect of 2-methylthio-ADP on
Effect of UTP and UDP on [Ca 2ϩ ] i in the presence or absence of TTX. In contrast to 2-methylthio-ADP, only 20 -36% of recorded neurons responded to UTP or UDP, in the presence of TTX (Table 2) , and the peak amplitude to either UTP or UDP was smaller than that to 2-methylthio-ADP or the P2YR agonist cocktail. This suggests that P2Y 2 R, P2Y 4 R (UTP is the most potent agonist to these two subtypes), and P2Y 6 R (for which UDP is the most potent agonist) may also be expressed, although to a lesser extent than P2Y 1 R, in subpopulations of SON neurons. A significantly larger percentage of neurons (83%) responded to UTP in the absence of TTX, suggesting a role for P2Y 2 Rs and/or P2Y 4 Rs in regulating local afferents to SON neurons.
PR Subtypes Activated by ATP: Effect of P2Y 1 R Antagonist
The possibility that the P2Y 1 subtype of P2YRs is primarily responsible for the non-P2XR mediated, ATP-induced increase in [Ca 2ϩ ] i in SON was further evaluated using a P2Y 1 R subtype selective antagonist, MRS2179 (2). The ATP-stimulated increase in [Ca 2ϩ ] i was greatly attenuated by MRS2179 (100 M, Fig. 7, A and D) . The attenuated response in the presence of MRS2179 was not due to the prior exposure to ATP, because robust ATP responses were observed in subsequent experiments in which the order of exposure was reversed (e.g., first ATP ϩ MRS2179 followed by a second exposure to ATP alone). In those experiments, combined treatment with MRS2179 and PPADS further reduced, but did not completely abolish, the [Ca 2ϩ ] i response to ATP (Fig. 7, B and D) , and in Ca 2ϩ -free perfusion medium, the response to ATP is barely noticeable in the presence of MRS2179 (Fig. 7, C and D) .
DISCUSSION
Although prior studies on ATP stimulation of VP and OT release by this laboratory (13) , as well as Ca 2ϩ -imaging experiments in dispersed SON neurons, supported a role for P2XRs in the response to ATP (21), the current studies provide extensive evidence for involvement of P2YRs as well as P2XRs. The expected intracellular signaling cascades initiated by activation of these two receptor types are summarized in Fig. 8 . As shown, P2XR activation could induce Ca 2ϩ influx via direct activation of the Ca 2ϩ -permeable P2XR and via indirect activation of voltage-sensitive Ca 2ϩ channels. Activation of P2YRs induces release of Ca 2ϩ from intracellular stores as a result of generation of IP 3 . In the present studies, the conclusion that both P2XRs and P2YRs contribute to the Ca 2ϩ response to ATP is supported by evidence from experiments employing techniques to assess the source of the Ca 2ϩ , as well as experiments utilizing selective receptor antagonists and agonists to identify the type of PRs activated. This dual approach is important, because neither approach alone is com- pletely definitive. The receptor antagonists do not block all receptor subtypes and are not completely selective for either P2XR or P2YR subtypes. For example, PPADS blocks the P2X 1 R, P2X 2 R, and P2X 3 R, but not P2X 4 R, P2X 6 R, and P2X 7 R subtypes. Furthermore, in addition to the signal cascades shown in Fig. 8, other The observation that a selective P2Y 1 R agonist induced a large increase in [Ca 2ϩ ] i in essentially all SON neurons suggests that these receptors may play a prominent role in regulating the activity of SON neurons and, therefore, the release of VP and OT from the posterior pituitary. This raises the important question of why prior studies did not find evidence for P2YR expression in SON or their involvement in ATP-mediated hormone release. The prior Ca 2ϩ -imaging studies were performed in acutely dissociated SON neurons (21) . In these studies, the ATP-induced increase in [Ca 2ϩ ] i was abolished by removal of extracellular fluid Ca 2ϩ , indicating that the response was completely dependent on Ca 2ϩ influx. Possible explanations for this difference include the loss of functional P2YRs during the dissociation procedure, potentially as a result of enzymatic damage to the receptors or shearing off of dendritic processes. In the HNS explant preparation used in the present studies, the SON neurons retain their neuritic processes, and the cell membrane is not exposed to enzymatic treatments. In the hormone release studies, the same organotypic explant preparation was used as in the present Ca 2ϩ imaging experiments (23) . Therefore, receptor loss by the above mechanisms is unlikely. However, a major difference between the two experiments is the end point studied. In the present experiment, the focus is on the cell body, whereas the end point of hormone release, although it includes activation of perikaryal receptors, is also influenced by regulatory mechanisms at the nerve terminal in the posterior pituitary. ATP acts directly on the nerve terminals and pituicytes in the posterior pituitary. It stimulates VP release from the isolated neural lobe and from isolated neurohypophyseal nerve terminals via a P2X 2 R (22, 25). Therefore, it is possible that P2XR-mediated mechanisms predominate in the ATP stimulation of hormone release from in vitro preparations in which both hypothalamus and posterior pituitary are exposed to exogenous ATP. Further studies are warranted to evaluate the relative importance of P2XRs and P2YRs in neurohypophyseal hormone release induced by physiological stimuli that release endogenous ATP in SON.
One earlier study did provide evidence for P2YRs in SON (11) . This was an electrophysiological study in which 77% of SON neurons were excited by UTP, and the response was not blocked by PPADS. Although the percentage of cells responding to UTP is similar to that in the present study (83%, Table  2 ), an important difference is that, in the present study, only 20% of neurons responded to UTP in the presence of TTX. This suggests a role for P2Y 2 R and/or P2Y 4 R in regulating local afferents innervating the SON neurons, as well as mediating postsynaptic responses in a subset of neurons. Although Hiruma and Bourque (11) reported that their UTP response was TTX insensitive, only three neurons were tested in the presence of TTX.
Experiments designed to evaluate the source of the Ca 2ϩ rise induced by ATP utilized established strategies, i.e., Ca 2ϩ -free medium to evaluate influx, thapsigargin to evaluate release from intracellular stores, and cadmium to evaluate influx through voltage-sensitive Ca 2ϩ channels. As anticipated, P2XR activation induced Ca 2ϩ influx through both voltage- sensitive Ca 2ϩ channels and P2XR, but perhaps surprising was the finding that P2YR activation not only induced Ca 2ϩ release from thapsigargin-sensitive stores (ϳ80%), but also induced Ca 2ϩ influx (the remaining 20% of the response). Possible mechanisms inducing this release include the following. 1) Activation of P2XRs by these agonists. This is not likely to be the explanation, since ATP still induced a small increase in [Ca 2ϩ ] i in thapsigargin-pretreated explants exposed to PPADS or iso-PPADS (Fig. 4, B and D) . 2) IP 3 stimulation of Ca 2ϩ influx. P2YR activation of Ca 2ϩ influx was reported previously in oviduct mucosal cells (1) . In these cells, IP 3 receptor activation was required for the Ca 2ϩ influx, and IP 3 receptors were localized to the plasma membrane, leading to the hypothesis that plasma membrane IP 3 receptor activation may directly trigger Ca 2ϩ influx. IP 3 -induced Ca 2ϩ influx has also been reported in Xenopus oocytes (7) , but, to our knowledge, remains to be demonstrated in neurons. 3) Protein kinase Cinduced Ca 2ϩ influx. Other G q/11 -coupled receptors (e.g., muscarinic receptors) alter Ca 2ϩ influx by activation of "receptoroperated Ca 2ϩ -channels" in neurons (17) . Although the molecular mechanism mediating this phenomenon remains to be elucidated, the transient receptor potential vanilloid (TRPV) family of nonselective ion channels is a potential candidate. In SON, the stretch-inactivated cation channels involved in osmoreception, a major physiological regulator of VP secretion, are nonselective cation channels (20) , and recent evidence suggests that these channels may be a variant of the TRPV1 channel (18) . The stretch-inactivated cation channels in SON have previously been shown to be modulated by excitatory peptides, such as angiotensin, neurotensin, and cholecystokinin (4). All of these peptides activate G q/11 -coupled receptors (12, 14, 16, 26) , and a G q/ll -coupled P2YR has been shown to activate TRPV1 receptors in Neuro 2a cells (15) . Thus, although further experiments are required to determine whether stretch-inactivated cation channels or TRPV1 channels contribute to the Ca 2ϩ response to ATP in SON neurons, it is an intriguing possibility to pursue. If ATP can modulate channels involved in osmoreception via activation of P2YRs, it may elucidate the mechanism underlying the well-recognized modulation of osmotic regulation of VP secretion by hemodynamic stimuli (8, 24) .
